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https://doi.org/10.1016/j.ajic.2019.03.016The contaminated surface environment in the rooms of hospitalized patients is an important risk factor for 
the colonization and infection of patients with multidrug-resistant pathogens. Improved terminal cleaning 
and disinfection have been demonstrated to reduce the incidence of health care−associated infections.
In the United States, hospitals generally perform daily cleaning and disinfection of patient rooms. How-
ever, cleaning and disinfection are limited by the presence of the patient in room (eg, current ultraviolet 
devices and hydrogen peroxide systems cannot be used) and the fact that after disinfection pathogenic 
bacteria rapidly recolonize surfaces and medical devices/equipment. For this reason, there has been great 
interest in developing methods of continuous room disinfection and/or “self-disinfecting” surfaces. This 
study will review the research on self-disinfecting surfaces (eg, copper-coated surfaces and persistent 
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ed by the Centers for Disease
K000164).In 1991, Weinstein described the contribution of different sources
of pathogens to health care−associated infections (HAIs).1 He noted
that the majority of HAIs were due to the patient’s endogenous flora
but stated that 20%-25% were due to contamination of the environ-
ment or to other sources (eg, food, air, and personnel carriers). In the
past decade, significant evidence has accumulated that contaminated
environmental surfaces and noncritical patient care devices play an
important role in the transmission of several key health care−associ-
ated pathogens, including methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant enterococci (VRE), Clostridioides diffi-
cile, Acinetobacter spp., and norovirus.2-8 Multiple studies have dem-
onstrated that these pathogens can persist on hospital surfaces from
days to weeks, frequently contaminate environmental surfaces in
rooms of colonized or infected patients, may contaminate the gloves
of health care personnel (HCP) or transiently colonize the hands of
HCP, leading to patient-to-patient transmission, and cause outbreaks
in which environmental transmission likely played an importantrole.2-8 Multiple studies have demonstrated that contact with the
environment in a room housing a patient with a multidrug-resistant
organism (MDRO) frequently leads to contamination of the gloves or
hands of the HCP.9-11 In an important study, Kundrapu et al12 demon-
strated that daily disinfection of high-touch surfaces in patient rooms
with C difficile and MRSA colonization reduced acquisition of the
pathogens on hands after contacting high-touch surfaces and reduced
hand contamination of HCP caring for patients.
The Centers for Disease Control and Prevention’s (CDC’s) Guideline
for Disinfection and Sterilization in Healthcare Facilities recommends
that environmental surfaces in hospital rooms be disinfected (or
cleaned) on a regular basis (eg, daily, 3 times per week) and when
surfaces are visibly soiled (category II recommendation).13 Studies of
environmental cleaning during terminal disinfection of hospital
rooms have demonstrated that the majority of surfaces are inade-
quately cleaned.14-16 Structured education and procedural interven-
tions (eg, use of fluorescent markers to assess adequate cleaning with
feedback to environmental service personnel) have been demon-
strated to improve cleaning.15,16 However, despite the improvement
shown by such programs, cleaning still remains inadequate. For this
reason, multiple methods for providing continuous room disinfection
have recently been developed (Table 1).17-21 Unfortunately, the “no-
touch” methods that are currently available for terminal room
Table 1
Continuous room disinfection technologies
Room disinfection technologies
 Visible light (ie, “blue light,” 400-470 nm)
 Dilute hydrogen peroxide
 Far UV-C (207-222 nm)
“Self-disinfecting” surfaces
 Surface chemical disinfectants with persistence
^ Quaternary ammonium compound-based agents
^ Organosilane compounds
 Heavy metals: silver, copper
 Others
^ Altered topography
^ Antimicrobial peptides bound to surfaces
^ Photoactivated surfaces (eg, TiO2, toluidine blue O, rose bengal)
^ Anti-adhesive surfaces (eg, super hydrophobic surfaces)
^ Attachment of bacteriophages to surfaces
^ Surface coating with carbon nanotubes, graphene, or diamond-like carbonsdisinfection, such as ultraviolet (UV) light devices and hydrogen per-
oxide systems, cannot be used with persons in the room and, there-
fore, are not suitable for continuous room disinfection if patients or
HCP are present.21-24 This article will provide an update and expand
on our previous review on “self-disinfecting” surfaces. The study is
also focused on the recent progress in developing continuous room
disinfection technologies.17CONTINUOUS ROOM DISINFECTION TECHNOLOGIES
Visible light (blue light)
The electromagnetic spectrum includes visible light (ie, electro-
magnetic spectrum detected by the human eye), with a wavelength
of 400-760 nm, and UV light, with a spectrum of 100-400 nm. UV
light is further divided into UV-A light (315-400 nm), UV-B light
(280-315 nm), and UV-C light (100-280 nm). UV-C light (254 nm) is
germicidal, and room disinfection units producing UV-C light have
been shown to effectively decontaminate intentionally contaminated
surfaces and naturally contaminated room surfaces.21-24 Multiple
clinical trials have demonstrated that UV-C room disinfection devices
can reduce the likelihood that a patient subsequently admitted to the
room that previously housed a patient colonized or infected with a
multidrug-resistant pathogen will acquire the pathogen.21 Further,
some studies have demonstrated a facility-wide decrease in multi-
drug-resistant pathogens.21
More recently, studies assessing the antimicrobial inactivation by
visible light (“blue light”) have been reviewed.25 Wang et al noted
that blue light in the spectrum of 400-470 nm has demonstrated its
intrinsic antimicrobial properties, resulting from the presence of
endogenous photosensitizing chromophores in pathogenic microbes
and, subsequently, its promise to counteract antibiotic resistance. The
utility of 405-nm blue light for the inactivation of health care−associ-
ated pathogens and its potential role for environmental disinfection
and infection control have been reviewed.25,26 In evaluating studies
of blue light against health care−associated pathogens, it is important
to note that the germicidal activity of both UV-C light and blue light
depend on several factors, including pathogen susceptibility (spores
are the most resistant), wavelength, light intensity, distance (energy
falls off as the square of the distance), duration of exposure, organic
load, and orientation to the light source.27-29
Halstead et al30 assessed the effectiveness of a light-emitting diode
at 400 nm to kill 34 different bacterial strains that commonly cause
HAIs, including Acinetobacter baumannii, Enterobacter cloacae, Pseudo-
monas aeruginosa, Escherichia coli, Klebsiella pneumoniae (including
NDM-1), Staphylococcus aureus, and Enterococcus faecium. Allplanktonic-phase bacteria were susceptible to blue light, with the
majority (71%) demonstrating ≥5 log10 decrease in viability after
15-30 minutes of exposure (54-108 J/cm2). More recently, Halstead
et al31 assessed the effectiveness of blue light at 405 nmagainst several
strains of carbapenem-producing Enterobacteriaceae in 72-hour-old
biofilms. All carbapenem-producing Enterobacteriaceae strains were
susceptible to the blue light, with increasing reductions in seeding
with increasing durations of exposure (ie, 5, 15, and 30 minutes). At
30 minutes, reductions in biofilm seeding of >80% were observed for
11 of the 12 isolates. Barneck et al32 studied the effectiveness of light-
emitting diodes at 405 nm against S aureus, Streptococcus pneumoniae,
E coli, and P aeruginosa. Dose-dependent inactivationwas observed for
all species. At the highest radiant exposure levels (ie, 132 J/cm2),
reductions of >5 log10 were observed for bacteria strains tested. Wang
et al33 demonstrated that blue light at 415 nm inactivated >3 log10
P aeruginosa in 24- and 72-hour-old biofilms exposed for 72 minutes
at 100 mW/cm2. Blue light has been demonstrated to inactivate Can-
dida albicans and other fungal species.34-36 In addition, blue light has
been demonstrated to inactivate spores of Bacillus subtilis, B megate-
rium, and C difficile, although the dose required for inactivation of
endospores is significantly higher compared with vegetative cells.37
Additional in vitro studies have been summarized.25
Several investigators have assessed blue light at 405 nm for
continuous room disinfection of a “mock” hospital room38 or sin-
gle-bed inpatient or outpatient rooms.39,40,41 The studies in occu-
pied patient rooms were conducted with adherence to standard
cleaning and/or disinfection protocols and with the blue light
activated only during daylight hours (Table 2). These studies dem-
onstrated a consistent 1- to 2-log10 reduction of surface bacteria.
Surface bacterial levels increased when the lights were not oper-
ating. Importantly, Rutala et al was unable to demonstrate a
reduction in C difficile in a mock patient room with ceiling blue
light units likely because the higher energy required to inactivate
spores was not achieved. The studies in occupied rooms did not
report any adverse patient events; however, there was no men-
tion of a systematic assessment for adverse events.
In conclusion, studies of blue light demonstrated a consistent
1- to 2-log10 reduction of surface bacteria. Given that hospital
room surfaces generally have <2 log10 bacteria, this may be suffi-
cient inactivation to reduce the risk of acquisition/transmission of
pathogenic bacteria to patients. However, no clinical trials of blue
light have assessed whether their use can lead to a reduction in
HAIs.Other room systems for continuous room disinfectionDilute hydrogen peroxide
As mentioned previously, hydrogen peroxide systems have dem-
onstrated to inactivate >4 log10 on surfaces inoculated with MDRO
placed in patient rooms.24 Clinical trials have shown when such units
are used for terminal disinfection in rooms previously occupied by a
patient colonized or infected with an MDRO, these systems may
reduce the risk of a subsequent patient admitted to room developing
colonization or an infection with the MDRO.44 However, because of
the high level of hydrogen peroxide achieved by these systems, nei-
ther the patients nor the HCP can occupy the room. Recently, systems
have been developed that produce low levels of hydrogen peroxide
that can be used in an occupied room. Rutala et al45 tested one such
system located outside of a model patient room but were unable to
demonstrate inactivation of several bacteria (ie, MRSA, VRE, multi-
drug resistance-A baumannii) inoculated onto test surfaces and placed
in the room. To our knowledge, no clinical trials of dilute hydrogen
peroxide systems have been published to date in the peer-reviewed
literature.
Table 2
Effectiveness of “blue light” at 405 nm to decontaminated patient rooms
Location Operating hours
Standard EVS
cleaning Results Author, year
Orthopedic OR — Yes 81% (P = .017) reduction in CFU in OR test room after
installation of visible-light system, and 49%
(P = .015) compared with a control OR room. SSIs in
treated room decreased from 1.4% to 0.4% (P = .029)
Murrell, 201941
Mock patient room 24 h No 90% reduction of MRSA (10 h), VRE (15 h), MDR-Aci-
netobacter baumannii (15 h), C difficile (NA)
Rutala, 201838
Burn room, unoccupied 24 h Yes »90% reduction of surface bacterial levels Maclean, 201039
Burn room, occupied by
MRSA patient
8 AM to 10:15 PM Yes 56%-85% reductions surface bacterial levels and 56%




14 h Yes 27%-75% reduction in surface bacterial levels Bache, 201242
Burn unit, occupied
outpatient room
While clinic operating (8 h) Yes 61% reduction in surface bacterial levels Bache, 201242
ICU, occupied inpatient
room
7:30 AM to 10 PM Yes Reductions of surface bacterial levels of up to 67% Maclean, 201343
Burn unit, occupied
inpatient rooms
8 AM to 10 PM Yes 22%-86% reduction in mean number of surface
bacteria
Bache, 201840
CFU, colony forming units; ICU, intensive care unit;MDR, multidrug resistance; MRSA, methicillin-resistant Staphylococcus aureus; NA, sustained reduction not achieved; OR, operat-
ing room; SSIs, surgical site infections; VRE, vancomycin-resistant enterococci.Far UV-C light
Although far UV-C light (ie, 207-222 nm) has not been shown to
induce mammalian skin damage,46 it has efficiently inactivated bacte-
ria such as S aureus47 and aerosolized the H1N1 influenza virus.48 To
our knowledge, no clinical trials of far UV-C have been published.
SELF-DISINFECTING SURFACES
Background
In recent years, a number of different technologies have been
developed in an attempt to devise self-disinfecting surfaces
(Table 1).17-19,49-54 Such surfaces have also been called “self-sanitiz-
ing,” and because microbial inactivation requires direct contact with
the surface, the term “contact killing” has also been used. This section
will review the most promising self-disinfecting” surface technolo-
gies. The advantages and disadvantages of currently proposed self-
disinfecting surfaces are summarized in Table 3.Table 3
Advantages and limitations of currently proposed self-disinfecting surfaces in hospital
rooms
Advantages
 Provides continuous disinfection of environmental surfaces
 Does not depend on adequacy of cleaning/disinfection by environmental
service staff
 Broad-spectrum antimicrobial activity
 Very low or no toxicity to humans
Current limitations
 Impossible to impregnate or to coat all possible room surfaces and medical devi-
ces used in a hospital room
 Efficacy of self-disinfecting surfaces to decrease HAIs has not been conclusively
demonstrated in clinical trials (best data are for copper but clinical trials have
had mixed results)
 Possible development of resistance by microbes to the self-disinfecting method
(eg, microbial resistance to silver and copper have been demonstrated).
 In general, modest reductions in surface contamination (ie, 1-2 log10 reductions)
demonstrated
 Durability with repeated cycles of cleaning and disinfection not yet evaluated
(best data are for copper but even with copper, data on durability are limited)
 Cost of purchasing and installing self-disinfecting surfaces is not available
 Cost-effectiveness of self-disinfecting surfaces has not been demonstrated
NOTE: Adapted fromWeber DJ, Rutala WA. Am J Infect Control 2013;41(Suppl):31-5.18
HAIs, health care−associated infections.Surface disinfectants with persistenceQuaternary ammonium compounds
Quaternary ammonium compounds are widely used for low-level
disinfection of surfaces in health care facilities.55,56 In a study of disin-
fection of computer keyboards, Rutala et al57 demonstrated that all 3
tested quaternary ammonium compounds showed excellent sus-
tained activity against VRE, and antimicrobial activity was maintained
over the entire 48-hour test period. Similarly, all 3 quaternary ammo-
nium compounds demonstrated sustained activity against P aerugi-
nosa, but at a level less than that for VRE.57 However, the germicidal
activity of the quaternary ammonium compounds was lost by wiping
the treated areas with a soapy solution.57 More recently, Tamimi
et al58 demonstrated that a formulation of a quaternary ammonium
organosilane compound that binds to surfaces produced long-term
residual disinfecting activity. In this study, the average bacterial count
on all treated surfaces was reduced by >99% for at least 8 weeks after
treatment. Overall, average levels of bacteria never returned to those
observed before treatment even after 15 weeks. Antibiotic-resistant
bacteria were found on 25% of the sites tested before treatment, but
were isolated at only 1 site during the 15 weeks after treatment.
Recently, Rutala et al investigated the persistent antimicrobial activ-
ity of a novel quaternary ammonium disinfectant. Surfaces were
treated with the novel disinfectant, allowed to dry, and then abraded
using a standardized abrasion machine under multiple alternating
wet and dry wipe conditions interspersed with 6 re-inoculations.
After 24 hours, the surface was re-inoculated a final time and the abil-
ity of the disinfectant to kill >99.9% of test microbes within 5 minutes
measured on 3 test surfaces (ie, glass, Formica, and stainless steel).
At the 24-hour time point, the novel disinfectant achieved a 3- to
5-log10 reduction in 5 minutes of S aureus, VRE, Candida auris, and
carbapenem-resistant E coli.59 A 1.5- to 2.1-log10 kill was noted for
carbapenem-resistant Enterobacter sp and Klebsiella pneumoniae.
Schmidt et al compared a “trial” disinfectant (70% ethanol with <1%
mixed quaternary ammonium chloride plus other proprietary agents)
applied to patient bed rails and 2 commonly used hospital disinfec-
tants (Cavicide, Metrex, Orange, CA; Virex II 256, Diversey, Charlotte,
NC).60 The trial disinfectant was found superior to the other agents
over a 24-hour period. However, the difference between the trial dis-
infectant and the comparators was <1 log10.
Although only limited data on novel quaternary ammonium com-
pounds exists, they show promise for providing continuously active
disinfection. Further studies and clinical trials are warranted to assess
efficacy and durability.
Organosilanes
Organosilane compounds are comprised by a surfactant plus an
antimicrobial substance such as a quaternary ammonium moiety.19
These compounds are designed to minimize bacterial contamination
of surfaces by maintaining their antimicrobial activity on surfaces for
weeks to months. As noted by Boyce,19 the ability of these com-




Elements that form positive ions (ie, cations) by losing electrons
during chemical reactions are termed metals. Approximately 65 ele-
ments possess these qualities, have a specific gravity >5, are consid-
ered the “heavy” metals. Although most metals are either insoluble
or extremely rare, and their effects on biologic systems are of minor
importance, >30 heavy metals may potentially interact with microor-
ganisms.18,61 Heavy metals influence microorganisms by affecting
their growth, morphology, and biochemical activities. Many metals
are essential to life (eg, sodium [Na], potassium [K], calcium [Ca],
and iron [Fe]). Toxicity is a result of blocking of functional groups of
important molecules (eg, enzymes, polynucleotides, transport
systems for essential nutrients, and ions), displacement of or substi-
tution of essential ions from cellular sites, denaturation and inactiva-
tion of enzymes, and disruption of cellular and organelle membrane
integrity. Virtually all metals, whether essential or nonessential, can
exhibit toxicity above certain threshold concentrations, which for
highly toxic metals may be extremely low.
Resistance to metals has been described in microbes and is medi-
ated by multiple mechanisms. First, metal ions may be converted into
less toxic forms by the action of enzymes, oxidases, and reductases.
Second, sequestration and binding to toxic metals in the cell wall or
within the cell may occur. Third, altered uptake pathways may result
in blocking of cellular uptake. Finally, an enhanced, highly specific
efflux systemmay decrease intracellular concentrations. As with anti-
biotic resistance, bacterial resistance to the toxic effects of heavy met-
als may be plasmid mediated. The most commonly used metals for
treatment of human illnesses have been silver, copper, and mercury.
In this section, we will focus on studies that have assessed the use of
silver, copper, and titanium dioxide for surface disinfection.
Silver
Silver compounds are currently used for a variety of medical pur-
poses such as topical antisepsis (eg, silver nitrate and silver sulfadia-
zine) and antimicrobial-resistant indwelling devices (eg, central
venous catheters).18,54 Silver ions have the highest level of antimi-
crobial activity of all the heavy metals.61,62 Although many mecha-
nisms for silver’s bactericidal activity have been proposed, the
observed bactericidal efficacy of silver is thought to be through the
strong binding with disulfide (S-S) and sulfhydryl (-SH) groups
found in the proteins of microbial cell walls.62 Through this binding
event, normal metabolic processes are disrupted, leading to cell
death. Both intrinsic and acquired silver resistance have been well
described in bacteria.62,63
Silver may be added to polymers to confer antimicrobial activity
and has been incorporated into consumer products such as toys, tele-
phones, and infant pacifiers.61 In health care, products incorporating
silver have included clothing (eg, scrubs), fabrics (eg, sheets), and sur-
faces.18,52,61,64 One product (Surfacine, Surfacine Development Com-
pany, Tyngsborough, MA) has been assessed for use as a self-
disinfecting surface in hospitals.65 It incorporates a water-solubleantimicrobial compound (silver iodide) in a surface-immobilized
coating (a modified poly-hexamethlyenebiguanide) that is capable of
chemical recognition and interaction with the lipid bilayer of the bac-
terial outer cell membrane by electrostatic attraction. Microorgan-
isms contacting the coating accumulate silver until the toxicity
threshold is exceeded. Surfacine can be applied to inanimate surfaces
by dipping, brushing, or spraying without prior surface treatment.
Surfaces to which this agent had been applied have been shown to
kill 3.3-4.3 log10 S aureus and 2.2-4.8 log10 P aeruginosa hours after
application of Surfacine.66 In addition, a >3 log10 kill of MRSA and
VRE was also achieved.66 Residual activity of Surfacine against VRE
has been shown for 13 days.65 The antibacterial effect of a silver/zinc
zeolite ceramic coating on stainless steel has been demonstrated by
challenge with S aureus, E coli, and P aeruginosa, but to date there are
no studies of actual hospital surfaces coated with a silver/zinc zeo-
lite.67,68 In addition, we are unaware of any published studies assess-
ing the ability of silver-coated or -impregnated surfaces to reduce the
microbial contamination on environmental surfaces in actual hospital
rooms or to decrease the incidence of HAIs.
Copper
The use of copper as an antimicrobial on surfaces has been
reviewed.17-19,69-77 Copper is an essential trace element in most living
organisms, and >30 types of copper-containing proteins have been
described.69-71 The use of copper by humans dates back to the 5th
and 6th millennia BC.18,69,70 Ancient civilizations used copper or cop-
per compounds to prevent the growth of barnacles on the hulls of
ships and as a medicinal agent. In the 19th and 20th centuries, inor-
ganic copper preparations were used to treat chronic adenitis,
eczema, impetigo, tuberculous infections, and syphilis.70 The cause of
bacterial cell death to exposure to copper may relate to its ability to
accept and donate single electrons leading to the generation of
reactive oxygen species, resulting is cell lysis.18,19,52,61 In health care
facilities, the most well-studied use of copper has been as a self-disin-
fecting surface; however, many other uses have been studied, includ-
ing copper-containing paints, fabrics, hand rubs, microfiber cleaning
cloths, pens, and fins within air-conditioning units.18,61
Multiple studies have assessed the contact killing of microbes by
copper surfaces.18,70 Contact with copper has been demonstrated to
kill a variety of health care−associated pathogens, including S aureus
(including MRSA), enterococcus, E coli, K pneumoniae, A baumannii, P
aeruginosa, and Mycobacterium tuberculosis.70-72 In general, contact
killing of vegetative bacteria and fungi occurs rapidly with >6 log10
inactivation per hour. Spores (eg, C difficile) are inactivated more
slowly, but >3 log10 are inactivated within 24 hours.18 According to
Grass et al,70 a few general principles can be drawn from these in
vitro studies: higher copper content of alloys, higher temperature,
and higher relative humidity increase the efficacy of killing. Treat-
ments that lowered corrosion rates (eg, application of corrosion
inhibitors or a thick copper oxide layer) lowered the antimicrobial
effectiveness of copper surfaces. As with silver, microbes may exhibit
resistance to copper.
Multiple studies of copper-coated surfaces or devices have been
conducted in the health care setting comparing the level and fre-
quency of surface contamination with control surfaces.74 Studies
have either used concurrent non-copper-coated control surfaces or a
crossover design. Muller et al51 reported that 5 of 7 copper studies of
copper-coated surfaces or fabrics reviewed demonstrated a signifi-
cant reduction in quantitative bacterial contamination of <1 log10
(range, <1-2 log10).Limitations of the studies noted by Muller et al51
included lack of blinding, lack of randomization, and, in general, fail-
ure to measure potential confounding factors (eg, hand hygiene com-
pliance and effectiveness of cleaning by environmental services) or
report any patient-level data. Similar to previous studies, 2 additional


















































































































































































































































































































































































































































































































































































































































































contamination on copper-coated surfaces compared with control
surfaces of 1-2 log10.76,77 Importantly, resistance to copper has been
described in microbes.
Three clinical trials have been published in the English literature
that assessed the effectiveness of copper-coated surfaces to reduce
HAIs (Table 4).77-79 Of these 3 trials, 2 reported that the intervention
arm (ie, copper) had a decreased incidence of HAIs, and 1 trial
reported no significant reduction in HAIs. Importantly, none of these
trials assessed the effectiveness of environmental cleaning and disin-
fection using fluorescent dye or adenosine triphosphate measure-
ments, and 1 of the trials did not assess compliance with hand
hygiene. Although Salgado et al described their trial as a randomized
clinical trial, Muller et al described this study as “low-quality evi-
dence due to inappropriate randomization and lack of blinding.”51 An
additional clinical trial has been published in the Spanish literature,
reporting no differences in the frequency of nosocomial infections as
well as no differences in the rates of ventilator-associated pneumo-
nia, catheter-associated urinary tract infections, or central line−asso-
ciated bloodstream infections.81 However, this study was limited by
its failure to achieve its intended sample size.
The potential advantages and limitations/deficiencies in the sci-
entific literature of studies assessing the efficacy of copper to reduce
surface contamination and HAIs in hospital rooms have been sum-
marized.74 In summary, copper-coated surfaces have demonstrated
the ability to inactivate many key pathogens associated with HAIs.
Multiple studies have demonstrated that copper-coated surfaces
can reduce the level of contamination on room surfaces by 1-2 log10.
To date, clinical trials have reported only rare adverse reactions
related to contact with a copper-coated surface, and only a limited
number of clinical trials have been published assessing whether
copper-coated surfaces reduce the incidence of HAIs. Published
studies have not yet shown copper-coated surfaces uniformly
reducing HAIs. Furthermore, these published studies have design
flaws, including failure to use a randomized design and failure to
account for all possible confounding variables (eg, hand hygiene
compliance and cleaning effectiveness). Thus, the use of copper-
coated surfaces to provide continuous room disinfection is promis-
ing, but additional carefully designed and appropriately powered
studies are required before this technology should be routinely
adopted to prevent HAIs.
Light-activated photosensitizers: Titanium dioxide
Light-activated photosensitizers, such as nanosized titanium
dioxide (TiO2) applied to surfaces using UV-A or visible light to gen-
erate reactive oxygen species that can disinfect surfaces, have been
evaluated.19,52,82,83 Titanium dioxide compounds doped with other
metals (eg, silver [Ag] and zinc [Zn]) have been assessed for antimi-
crobial activity. Such compounds have demonstrated inactivation of
pathogens (ie, viruses, bacteria, and fungi) associated with HAIs,
however the rate of decrease depends on thin film composition and
the illumination used.49,54 Kim et al performed a prospective cohort
study in a medical intensive care unit in which a titanium dioxide
photocatalyst was applied to high-touch surfaces and walls.83 In this
before-after study, there was a significant decrease in the rate of
MRSA acquisition after application of the photocatalyst (hazard
ratio, 0.37; P = .04) but a decrease in VRE or multidrug-resistant A
baumannii was not observed.84 The risk of developing hospital-
acquired pneumonia during the intervention compared to baseline
period was 0.46 (P = .03).84 In a before-after study conducted in a
long-term care facility, Pulliam83 coated all available surfaces with a
titanium dioxide compound and reported a 30% decrease in HAIs
(P = .02).83 However, a prospective (before-after) study by de Jong
et al84 reported that a titanium dioxide coating on all surfaces in an
intensive care unit had no effect on the microbial colonization of
surfaces.
Even if properly manufactured, the slow action time of the light-
activated photosensitizer, ion-doped, TiO2 nanoparticles would allow
it only to be a supplement to conventional surface disinfection.84
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